Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
Author:
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Subject
Biochemistry, medical,Clinical Biochemistry
Link
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2020/1452-82582004488S.pdf
Reference64 articles.
1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020; 395: 565-74.;
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med 2020; 382: 727-33.;
3. Sanders J M, Monogue M L, Jodlowski T Z, Cutrell J B. Pharmacologic treatments for coronavirus disease 2019 (covid-19): A review. JAMA 2020; 323: 1824-36. Accessed: 5/19/2020;
4. ClinicalTrials.gov. https://clinicaltrials.gov Access Date: 17.05.2020.;
5. Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight covid-19. Int J Antimicrob Agents 2020; 55: 105932-32.;
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug genetic associations with COVID-19 manifestations: a data mining and network biology approach;The Pharmacogenomics Journal;2022-09-28
2. In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir;Chemico-Biological Interactions;2022-09
3. Pharmacogenomics and Pharmacotranscriptomics of Glucocorticoids in Pediatric Acute Lymphoblastic Leukemia;Corticosteroids - A Paradigmatic Drug Class;2021-11-24
4. Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA;Journal of Medical Biochemistry;2021
5. Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers;Journal of Medical Biochemistry;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3